Skip to main content

Belite Bio, Inc

BLTE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001889109

In the last 90 days, Belite Bio, Inc insiders filed 0 open-market purchases and 4 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $1.44B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

13F holders, Q2 2022

Institutional positions in Belite Bio, Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
6
+6 vs. Q1 2022
Shares held
68.9K
+68.9K vs. Q1 2022
Total value
$2.15M
+$2.15M vs. Q1 2022
New holders
6
0 more added
Sold out
0
0 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BLTE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 6 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 6 institutionsQ3 2022: 8 institutionsQ4 2022: 7 institutionsQ1 2023: 8 institutionsQ2 2023: 6 institutionsQ3 2023: 7 institutionsQ4 2023: 17 institutionsQ1 2024: 11 institutionsQ2 2024: 11 institutionsQ3 2024: 15 institutionsQ4 2024: 22 institutionsQ1 2025: 18 institutionsQ2 2025: 18 institutionsQ3 2025: 34 institutionsQ4 2025: 69 institutionsQ1 2026: 75 institutionsQ2 2026: 80 institutions
Value heldQ2 2022: $2.15M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $2.15MQ3 2022: $3.87MQ4 2022: $25.9MQ1 2023: $25.4MQ2 2023: $14.9MQ3 2023: $3.17MQ4 2023: $7.10MQ1 2024: $2.23MQ2 2024: $8.52MQ3 2024: $3.69MQ4 2024: $17.8MQ1 2025: $9.91MQ2 2025: $4.51MQ3 2025: $169.3MQ4 2025: $1.15BQ1 2026: $1.42BQ2 2026: $1.44B
Institutions holding BLTE and their total value by quarter
QuarterHoldersValue
Q2 202680$1.44B
Q1 202675$1.42B
Q4 202569$1.15B
Q3 202534$169.3M
Q2 202518$4.51M
Q1 202518$9.91M
Q4 202422$17.8M
Q3 202415$3.69M
Q2 202411$8.52M
Q1 202411$2.23M
Q4 202317$7.10M
Q3 20237$3.17M
Q2 20236$14.9M
Q1 20238$25.4M
Q4 20227$25.9M
Q3 20228$3.87M
Q2 20226$2.15M
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Belite Bio, Inc; share changes are against Q1 2022.

Institutions holding BLTE in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Atria Wealth Solutions, Inc.49,463$1.54M0.03%+49,463New
Millennium Management LLC8,995$280.0K0.00%+8,995New
Qube Research & Technologies Ltd6,640$207.0K0.00%+6,640New
BI Asset Management Fondsmaeglerselskab A/S2,954$92.0K0.00%+2,954New
UBS Group AG683$21.0K0.00%+683New
Prestige Wealth Management Group LLC200$6.00K0.00%+200New